SCHEMBL4925929

SCHEMBL4925929

O=C(NO)c1ccccc1-c1ccccc1C(=O)Nc1cc2ccccc2cc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.52
KDM4E B2RXH2 3/20 0.49
MPO P05164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
KMT2A Q03164 4/20 0.48
SOS1 Q07889 1/20 0.47
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.46
EP300 Q09472 1/20 0.46
PRMT1 Q99873 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
NPC1 O15118 6/20 0.46
RAB9A P51151 4/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 2/20 0.45
MAPK1 P28482 1/20 0.45
NOD2 Q9HC29 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924045 0.92 KDM4E (0.53) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL4915600 0.87 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 (0.48) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL4927648 0.81 GAA (0.69) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL4916420 0.80 GAA (0.80) GAAKDM4ESMN1; SMN2HIF1AKMT2A
SCHEMBL3026631 0.77 GAA (0.64) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL4921271 0.76 KCNMA1 (0.74) GAASMN1; SMN2HIF1AKMT2ANPC1
SCHEMBL31354441 0.76 MEN1 (0.70) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL10724443 0.76 MEN1 (0.70) GAAKDM4EMPOSMN1; SMN2HIF1A
SCHEMBL12368153 0.75 KCNMA1 (0.71) GAAKDM4ESMN1; SMN2HIF1AKMT2A
Potassium SCHEMBL32681949 0.74 MEN1 (0.68) GAAKDM4EMPOSMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 GAA 1690/4885KDM4E 1359/4885MPO 34/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 GAA 1635/4885KDM4E 1265/4885MPO 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.